Peripheral arterial disease and diabetes: A clinical update

International Journal of Lower Extremity Wounds

Volumn 8, Issue 2, 2009, Pages 75-81

  Dinh, Thanh ^a   Scovell, Sherry ^b   Veves, Aristidis ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Diabetic foot; Microvascular reactivity; Peripheral arterial disease

Indexed keywords

ANGIOPLASTY; ARTERY DISEASE; BYPASS SURGERY; DIABETES MELLITUS; HUMAN; LIMB ISCHEMIA; MICROCIRCULATION; NEUROPATHY; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; STENT; WOUND HEALING;

DIABETES COMPLICATIONS; HUMANS; MICROCIRCULATION; MORBIDITY; PERIPHERAL VASCULAR DISEASES; VASCULAR SURGICAL PROCEDURES; WOUND HEALING;

EID: 65649107712     PISSN: 15347346     EISSN: 15526941     Source Type: Journal    
DOI: 10.1177/1534734609336768     Document Type: Review

References (44)

1. Dormandy J., Heeck L., Vig S. The natural history of claudication: risk to life and limb. Semin Vasc Surg. 1999 ; 12: 123-137. (Pubitemid 29259200)
2. Cheng SW, Ting AC, Lau H., Wong J. Survival in patients with chronic lower extremity ischemia: a risk factor analysis. Ann Vasc Surg. 2000 ; 14: 158-165. (Pubitemid 30149069)
3. Hirsch AT, Criqui MH, Treat-Jacobson D., et al. Peripheral arterial disease detection, awareness and treatment in primary care. JAMA. 2001 ; 286: 1317-1324. (Pubitemid 33015522)
4. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics-2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008 ; 117: e25 - e146.
5. Criqui MH Peripheral arterial disease: epidemiological aspects. Vasc Med. 2001 ; 6 (3, suppl 1). 3-7. (Pubitemid 33138269)
6. Marso S., Hiatt WR Peripheral arterial disease in patients with diabetes. J Am Coll Cardiol. 2006 ; 47: 921-929. (Pubitemid 43312751)
7. Bird CE, Criqui MH, Fronek A., Denenberg JO, Klauber MR, Langer RD Quantitative and qualitative progression of peripheral arterial disease by non-invasive testing. Vasc Med. 1999 ; 4: 15-21. (Pubitemid 29166736)
8. Adler AI, Boyko EJ, Ahroni JH, Smith DG Lower-extremity amputation in diabetes: the independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999 ; 22: 1029-1035. (Pubitemid 29293950)
9. Murabito JM, D'Agostino RB, Silbershatz H., Wilson WF Intermittent claudication: a risk profile from the Framingham Heart Study. Circulation. 1997 ; 96: 44-49. (Pubitemid 27298402)
10. Hiatt WR Medical treatment of peripheral arterial disease and claudication. N Engl J Med. 2001 ; 344: 1608-1621. (Pubitemid 32479915)
11. Strandness DE Jr, Priest RE, Gibbons GE Combined clinical pathological study of diabetic and non-diabetic peripheral arterial disease. Diabetes. 1964 ; 13: 366-372.
12. Menzoian JO, Lamorte WW, Paniszyn CC, et al. Symptomatology and anatomic patterns of peripheral vascular disease: differing impact of smoking and diabetes. Ann Vasc Surg. 1989 ; 3: 224-228.
13. King TA, DePalma RG, Rhodes RS Diabetes mellitus and atherosclerotic involvement of the profunda femoris artery. Surg Gynecol Obstet. 1984 ; 159: 553-556. (Pubitemid 15193903)
14. Goldenberg SG, Alex M., Joshi RA, Blumenthal HT Non atheromatous peripheral vascular disease of the lower extremity in diabetes mellitus. Diabetes. 1959 ; 8: 261-273.
15. Jaap AJ, Shore AC, Stockman AJ, Tooke JE Skin capillary density in subjects with impaired glucose tolerance and patients with type 2 diabetes. Diabet Med. 1996 ; 13: 160-164. (Pubitemid 26075525)
16. Malik RA, Newrick PG, Sharma AK, et al. Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy. Diabetologia. 1989 ; 32: 92-102. (Pubitemid 19096380)
17. Williamson JR, Kilo C. Basement membrane physiology and pathophysiology. In: Alberti KGMM, DeFronzo RA, Keen H, Zimmet P, eds. International Textbook of Diabetes Mellitus. Chichester, UK: John Wiley ; 1992: 1245-1265.
18. Veves A., King GL Can VEGF reverse diabetic neuropathy in human subjects ? J Clin Invest. 2001 ; 107: 1215-1218. (Pubitemid 32494535)
19. Veves A., Akbari CM, Primavera J., et al. Endothelial dysfunction and the expression of endothelial nitric oxide synthetase in diabetic neuropathy, vascular disease and foot ulceration. Diabetes. 1998 ; 47: 457-463. (Pubitemid 28104210)
20. Arora S., Pomposelli F., LoGerfo FW, Veves A. Cutaneous microcirculation in the neuropathic diabetic foot improves significantly but not completely after successful lower extremity revascularization. J Vasc Surg. 2002 ; 35: 501-505.
21. Lewis T. The Blood Vessels of the Human Skin and Their Responses. London, UK: Shaw; 1927.
22. Douglas WW, Ritchie JM The excitatory action of acetylcholine on cutaneous non-myelinated fibers. J Physiol. 1960 ; 150: 501-514.
23. Hamdy O., Abou-Elenin A., LoGerfo FW, Horton FW, Veves A. The contribution of nerve axon reflex-related vasodilation to the total endothelium-dependent vasodilation in the skin of diabetic patients with and without neuropathy. Diabetes Care. 2001 ; 24: 344-349. (Pubitemid 32119136)
24. Parkhouse N., LeQueen PM Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. N Engl J Med. 1988 ; 318: 1306-1309. (Pubitemid 18126829)
25. Libby P., Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105: 1135-1143. (Pubitemid 34212626)
26. Li YQ, Doyle JW, Roth TP, Dunn RM, Lawrence WT IL-10 and GM-CSF expression and the presence of antigen-presenting cells in chronic venous ulcers. J Surg Res. 1998 ; 79: 128-135. (Pubitemid 28467347)
27. Wallace HJ, Stacey MC Levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in chronic venous leg ulcers-correlations to healing status. J Invest Dermatol. 1998 ; 110: 292-296. (Pubitemid 28144608)
28. Higley HR, Ksander GA, Gerhardt CO, Falanga V. Extravasation of macromolecules and possible trapping of transforming growth factor-beta in venous ulceration. Br J Dermatol. 1995 ; 132: 79-85.
29. Pradhan AD, Manson JE, Rifai N., Buring JE, Ridker PM C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001 ; 286: 327-334. (Pubitemid 32656163)
30. Veraart JC, Verhaegh ME, Neumann HA, Hulsmans RF, Arends JW Adhesion molecule expression in venous leg ulcers. Vasa. 1993 ; 22: 213-218. (Pubitemid 24009425)
31. Faxon DP, Fuster V., Libby P., et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation. 2004 ; 109: 2617-2625. (Pubitemid 38720566)
32. LoGerfo FW, Gibbons GW, Pomposelli FB, et al. Trends in the care of the diabetic foot. Expanded role of arterial reconstruction. Arch Surg. 1992 ; 127: 617-621.
33. Levin M. The diabetic foot. Pathophysiology, evaluation, and treatment. In: Levin M, ed. The Diabetic Foot. St Louis, MO: Mosby; 1987.
34. Tannenbaum GA, Pomposelli FB Jr, Marcaccio EJ, et al. Safety of vein bypass grafting to the dorsal pedal artery in diabetic patients with foot infections. J Vasc Surg. 1992 ; 15: 982-988.
35. Londrey GL, Ramsey DE, Hodgson KJ, Barkmeier LD, Sumner DS Infrapopliteal bypass for severe ischemia: comparison of autogenous vein, composite, and prosthetic grafts. J Vasc Surg. 2001 ; 13: 631-636.
36. Harrington ED, Harrington ME, Schanzer H., Jacobson JH, Haimov M. The dorsalis pedis bypass-moderate success in difficult situations. J Vasc Surg. 1992 ; 15: 409-416.
37. Pomposelli FB, Kansal N., Hamdan AD, et al. A decade of experience with dorsalis pedis artery bypass: analysis of outcome in more than 1000 cases. J Vasc Surg. 2003 ; 37: 307-315. (Pubitemid 36236907)
38. Adam DJ, Beard JD, Cleveland T., et al. BASIL Trial Participants. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomized controlled trial. Lancet. 2005 ; 366: 1925-1934. (Pubitemid 41713982)
39. Klein WM, van der Graaf Y., Seegers J., Moll FL, Mali WP Long-term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: The Dutch Iliac Stent Trial Study. Radiology. 2004 ; 232: 491-498. (Pubitemid 38971291)
40. Schillinger M., Sabeti S., Loewe C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med. 2006 ; 354: 1879-1888. (Pubitemid 43872689)
41. Dormandy JA, Rutherford RB ; TASC Working Group. Trans Atlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). J Vasc Surg. 2000 ; 31: S1 - S296. (Pubitemid 30067386)
42. Norgren L., Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg. 2007 ; 33 (suppl 1). S1 - S75. (Pubitemid 46068992)
43. Giles, KA, Pomposelli FB, Hamdan AD, Blattman SB, Panossian H., Schermerhorn MD Infrapopliteal angioplasty for critical limb ischemia: relation of Trans Atlantic Inter Society Consensus class to outcome in 176 limbs. J Vasc Surg. 2008 ; 48: 128-136.
44. Kudo T., Chandra FA, Ahn SS The effectiveness of percutaneous balloon angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg. 2005 ; 41: 423-435. (Pubitemid 40523584)